ERSP referral
This article was originally published in The Tan Sheet
Executive Summary
The Electronic Retailing Self-Regulation Program refers International Nutrition Master to the Federal Trade Commission since the direct response marketer has failed to provide substantiation for its claims by a second deadline. ERSP takes issue with the truth and accuracy of the company's Spanish-speaking ads for Hepatol Complex. Problematic safety, performance and implied claims for the product include: "no risk of side effects," "helps your liver so it functions normally" and "if you suffer from any of these symptoms [including] headaches...gas, nausea, bad breath...pimples...you suffer from liver dysfunction." The claims came to ERSP's attention through an anonymous consumer complaint...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.